- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 685509 formulation 3
Total 361 results
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetic NephropathiesSpain, Australia, United States, Canada, China, Japan, Malaysia, United Kingdom, Mexico, Portugal, Denmark, Hong Kong, Poland, New Zealand, Argentina, Netherlands
-
Boehringer IngelheimCompletedDiabetic NephropathiesUnited States, Canada, Belgium, Czechia, Germany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimActive, not recruitingHypertension, PortalSpain, Denmark, United Kingdom, Singapore, Germany, Italy, Austria, Canada, Croatia, China, Taiwan, Netherlands, Belgium, United States, Korea, Republic of, Japan, Argentina, France, Switzerland, Portugal, Israel, Romania
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedChronic Kidney DiseaseSpain, Canada, Australia, United States, Japan, Malaysia, United Kingdom, China, Mexico, Denmark, Russian Federation, Germany, Portugal, Hong Kong, Poland, Argentina, New Zealand, Sweden
-
Boehringer IngelheimRecruitingScleroderma, SystemicUnited States, Belgium, Korea, Republic of, Australia, China, Taiwan, Spain, Israel, Japan, Mexico, Turkey, Germany, Italy, Brazil, France, Singapore, Canada, Philippines, United Kingdom, Switzerland, Finland, Greece, New Zealand, Den... and more
-
Boehringer IngelheimRecruitingSmall Cell Lung Carcinoma | Neuroendocrine NeoplasmsUnited States, Belgium, Spain, Korea, Republic of, United Kingdom, Germany, Japan, China, Taiwan, France, Portugal, Bulgaria
-
Boehringer IngelheimNot yet recruiting
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimCompletedArthritis, RheumatoidUnited States, Poland
-
Boehringer IngelheimCompletedHepatic Insufficiency | HealthyUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimRecruitingLiver Diseases | HealthyUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminatedSafety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid ArthritisArthritis, RheumatoidUnited States, Belgium, Bulgaria, Germany, Greece, Netherlands, Poland, Portugal, Spain
-
Boehringer IngelheimActive, not recruitingLiver Cirrhosis | Hypertension, PortalSpain, Germany, Canada, China, Austria, United States, Japan, France, Korea, Republic of, Romania
-
PfizerCompleted
-
Boehringer IngelheimCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States
-
MedImmune LLCCompletedType 2 Diabetes MellitusUnited States
-
GlaxoSmithKlineActive, not recruitingHerpes SimplexGermany, United States, Belgium, Canada, Spain, United Kingdom, Estonia, Australia
-
Boehringer IngelheimCompletedLupus NephritisSpain, United Kingdom, United States, Canada, Thailand, Germany, Italy, Japan, Serbia, Australia, Korea, Republic of, Mexico, Malaysia, Philippines, Poland, Portugal, Greece, Hong Kong, Czechia, France
-
PfizerNot yet recruitingHealthy ParticipantsUnited States
-
Boehringer IngelheimCompleted
-
Sanofi Pasteur, a Sanofi CompanyImmune DesignTerminated
-
Boehringer IngelheimCompletedAlzheimer DiseaseSpain, United Kingdom, Italy, United States, Canada, Germany, Greece, Austria, Norway, France, Japan, Hungary, Poland, Finland
-
Boehringer IngelheimCompletedSchizophreniaSpain, Korea, Republic of, United Kingdom, Taiwan, United States, Austria, Italy, Germany, Poland, Japan, Canada
-
Boehringer IngelheimCompletedArthritis, RheumatoidUnited States, Spain, Korea, Republic of, Thailand, Malaysia, Poland, Russian Federation, Serbia, Bulgaria, Chile, Estonia, Germany, Hungary, Ukraine
-
Universiti Sultan Zainal AbidinUniversiti Sains Malaysia; National University of MalaysiaCompletedAt Risk of Type 2 Diabetes MellitusMalaysia
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus | Infections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
Aragon Pharmaceuticals, Inc.Completed
-
Northwell HealthTerminatedNon-Alcoholic Fatty Liver Disease | Probiotics MeSH Descriptor Data 2018 | Interleukin-17 MeSH Descriptor Data 2018United States
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsUnited States, Belgium, Canada
-
Emergent BioSolutionsNational Institute of Allergy and Infectious Diseases (NIAID); Department of...CompletedBacillus Anthracis (Anthrax) InfectionUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsGermany, Estonia, Belgium, France
-
AllerganCompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
GlaxoSmithKlineWithdrawnRespiratory Syncytial Virus InfectionsFinland, United States, Spain
-
SCF PharmaInstitut de recherche clinique du littoral (IRCL)Recruiting
-
Boehringer IngelheimCompleted
-
GlaxoSmithKlineCompletedInfections, Respiratory Syncytial VirusCanada
-
Boehringer IngelheimCompletedCrohn DiseaseSerbia, United Kingdom, United States, Czechia, Germany, Greece, Poland, Russian Federation, Turkey, Israel, Belarus, Ukraine, Croatia, Bosnia and Herzegovina